Abstract:Background Hepatocyte carcinoma (HCC) is one of the most common malignancies worldwide. Despite many achievements in diagnosis and treatment, HCC mortality remains high due to the malignant nature of the disease. Novel approaches, especially for targeted therapy, are being extensively explored. Gene therapy is ideal for such purpose for its specific expression of exogenous genes in HCC cells driven by tissue-specific promoter. However strategies based on correction of mutations or altered expressions of genes responsible for the development/progression of HCC have limitations because these aberrant molecules are not presented in all cancerous cells. In the current work, we adopted a novel strategy by targeting the DNA replication step which is essential for proliferation of every cancer cell. Methods A recombinant adenovirus with alpha fetoprotein (AFP) promoter-controlled expressions of artificial microRNAs targeting DNA polymerases α, δ, ε and recombinant active Caspase 3, namely Ad/AFP-Casp-AFP-amiR, was constructed. Results The artificial microRNAs could efficiently inhibit the expression of the target polymerases in AFP-positive HCC cells at both RNA and protein levels, and HCC cells treated with the recombinant virus Ad/AFP-Casp-AFP-amiR exhibited significant G0/1 phase arrest. The proliferation of HCC cells were significantly inhibited by Ad/AFP-Casp-AFP-amiR with increased apoptosis. On the contrary, the recombinant adenovirus Ad/AFP-Casp-AFP-amiR did not inhibit the expression of DNA polymerases α, δ or ε in AFP-negative human normal liver cell HL7702, and showed no effect on the cell cycle progression, proliferation or apoptosis. Conclusions Inhibition of DNA polymerases α, δ and ε by AFP promoter-driven artificial microRNAs may lead to effective growth arrest of AFP-positive HCC cells, which may represent a novel strategy for gene therapy by targeting the genes that are essential for the growth/proliferation of cancer cells, avoiding the limitations set by any of the individually altered gene.

In Vitro Efficacy of Mda-7 Gene for Hepatocellular Carcinoma Gene Therapy Mediated by Human Ribosomal Dna Targeting Vector

[Construction and Expression of Recombinant Adenovirus Encoding MDA-7/IL-24 and Its Inhibitory Effect on Proliferation in Human Hepatocellular Carcinoma Cells].

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

Growth Inhibition and Apoptosis Induced by Adenovirus Mediated MDA-7/IL-24 Gene in Gallbladder Carcinoma of Nude Mice

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Construction of tumor-specific proliferation-deficient adenovirus vector and its primary study on selective expression in tumor cells

The effect of oncolyic adenovirus SG600-IL24 expressing human MDA-7/IL-24 on apoptosis of hepatocellular carcinoma cell lines

Gene Delivery Using a Receptor-Mediated Gene Transfer System Targeted to Hepatocellular Carcinoma Cells.

An RGD-modified MRI-visible Polymeric Vector for Targeted Sirna Delivery to Hepatocellular Carcinoma in Nude Mice.

Inhibition of MDR1 Expression in Hepatocellular Carcinoma Cell Bel-7402/R by Vector-Mediated RNA Interference

Antitumor and Antiangiogenic Activities of Anti-Vascular Endothelial Growth Factor Hairpin Ribozyme in Human Hepatocellular Carcinoma Cell Cultures and Xenografts

Non‐viral Ex Vivo Transduction of Human Hepatocyte Cells to Express Factor VIII Using a Human Ribosomal DNA‐targeting Vector

Enhanced Antitumor Effect of EGF R–targeted P21waf-1 and GM-CSF Gene Transfer in the Established Murine Hepatoma by Peritumoral Injection

Targeted Delivery of Chemically Modified Anti-Mir-221 to Hepatocellular Carcinoma with Negatively Charged Liposomes.

Adenovirus-mediated Human MDA-7/IL-24 Transfer Induces Apoptosis in Human Nasopharyngeal Carcinoma Cell CNE

Lentivirus‑mediated MDA7/IL24 Expression Inhibits the Proliferation of Hepatocellular Carcinoma Cells.

Therapeutic Targeting of Liver Cancer with A Recombinant Dna Vaccine Containing the Hemagglutinin-Neuraminidase Gene of Newcastle Disease Virus Via Apoptotic-Dependent Pathways

MDA7 Combined with Targeted Attenuated Salmonella Vector SL7207/pBud-VP3 Inhibited Growth of Gastric Cancer Cells.

Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma

Fiber-modified Adenoviral Vector Expressing the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene from the Human Telomerase Reverse Transcriptase Promoter Induces Apoptosis in Human Hepatocellular Carcinoma Cells